Tag: Mesoblast Limited

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Mesoblast Limited

Equities Analysts Set Expectations for Mesoblast limited's FY2020 Earnings (NASDAQ:MESO)

Added to Collection on: 2019-10-24 19:37:30

Tags for this article:

Economy
Finance
Regenerative biomedicine
Money
Mesoblast
Valuation
Price?earnings ratio
Securities research
Financial analyst
Mesoblast Limited

Click the tags to see associated articles and topics

View Article Details
Mesoblast (NASDAQ:MESO) Given “Buy” Rating at Maxim Group

Added to Collection on: 2019-12-22 07:37:30

Tags for this article:

Finance
Money
Economy
Regenerative biomedicine
Mesoblast
Stock market
Financial analyst
Securities research
Stock
Price?earnings ratio
Day trading
Mesoblast Limited

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To ...

Added to Collection on: 2021-04-29 12:11:15

Tags for this article:

Life Sciences
Biotechnology
Economy of the United States
Regenerative biomedicine
Economy of New York City
NASDAQ
Adverum Biotechnologies
Alnylam Pharmaceuticals
New York Stock Exchange
Biogen
Gilead Sciences
Mesoblast
Event Adverum Biotechnologies, Inc.
PTC Therapeutics Inc.
Akoya Biosciences Inc.
Axonics Inc.
PRA Health Sciences Inc.
Galectin Therapeutics Inc
Mesoblast Limited
Lucira Health Inc.
Horizon Therapeutics Public Limited Company
Verastem Inc.
NuVasive Inc.
Boston Scientific Corporation
IRadimed Corporation
ADVERUM
Lantheus Holdings Inc
Protara Therapeutics Inc.
Celldex Therapeutics Inc.
Shockwave Medical Inc
Decibel Therapeutics Inc.
Insulet Corporation
Celcuity Inc.
Integra LifeSciences Holdings Corporation

Click the tags to see associated articles and topics

View Article Details
Why the Mesoblast (ASX:MSB) share price is edging higher on Tuesday

Added to Collection on: 2021-08-10 02:48:45

Tags for this article:

Regenerative biomedicine
Mesoblast
Australian Securities Exchange
Chief financial officer
All Ordinaries
Mesoblast Limited

Click the tags to see associated articles and topics

View Article Details
Loss-Making Mesoblast Limited (ASX:MSB) Expected To Breakeven In The Medium-Term

Added to Collection on: 2021-08-25 01:18:45

Tags for this article:

Regenerative biomedicine
Mesoblast
Articles
Fusion energy gain factor
Investment
Nature
Mesoblast Limited

Click the tags to see associated articles and topics

View Article Details
Auditors Are Concerned About Mesoblast (ASX:MSB) - Simply Wall St News

Added to Collection on: 2021-09-04 22:41:15

Tags for this article:

Accounting
Finance
Business
Mesoblast
Regenerative biomedicine
Cash flow
Financial capital
Corporate finance
Fundamental analysis
Balance sheet
Equity
Debits and credits
Mesoblast Limited

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D ...

Added to Collection on: 2021-10-07 12:22:30

Tags for this article:

Life Sciences
Companies
Biotechnology companies
Economy of New York City
NASDAQ
Amgen
MorphoSys
Vertex Pharmaceuticals
Pluristem Therapeutics
PTC Therapeutics
ensysce biosciences, inc.
DURECT Corporation
Indaptus Therapeutics Inc.
Aziyo Biologics Inc.
eiger biopharmaceuticals inc
Minerva Neurosciences Inc
Aytu BioPharma Inc.
Orphazyme A/S
ROCKWELL MEDICAL , INC
Glaukos Corporation
Heron Therapeutics Inc
Longeveron Inc.
HCW Biologics Inc.
Catalyst Pharmaceuticals Inc
Hoth Therapeutics Inc.
DICE Therapeutics, Inc.
TELIGENT , INC
Aptinyx Inc.
Nuwellis Inc.
Adverum Biotechnologies Inc.
BiondVax Pharmaceuticals Ltd.
Spruce Biosciences Inc.
Mesoblast Limited
Chemomab Therapeutics, Ltd.
Kiniksa Pharmaceuticals Ltd
trevi therapeutics, inc.
Black Diamond Therapeutics, Inc.
Avenue Therapeutics Inc.
China SXT Pharmaceuticals Inc.
Amgen Inc.
POINT Biopharma Global Inc.
TCR2 Therapeutics Inc.
Pluristem Therapeutics Inc.
Forte Biosciences Inc.
Vertex Pharmaceuticals Incorporated
Oncorus Inc.
Year Moderna, Inc.
Acutus Medical Inc.
Neovasc Inc.
Spectrum Pharmaceuticals Inc.
Oyster Point Pharma Inc.
Incyte Corporation
Moleculin Biotech Inc.
Nautilus Biotechnology Inc.
Caladrius Biosciences Inc.
MORPHOSYS AG
Inhibikase Therapeutics Inc.
Galecto Inc.
MaxCyte Inc.
Immunic Inc
Kiromic BioPharma Inc.
Cellectis SA
Gamida Cell Ltd
BioSig Technologies Inc.
LumiraDx Limited
NRx Pharmaceuticals, Inc.
Stoke Therapeutics Inc
histogen inc
Calliditas Therapeutics AB
PTC Therapeutics Inc.
Solid Biosciences Inc.
Aravive Inc
Titan Pharmaceuticals Inc.
Roivant Sciences Ltd.
Liminal BioSciences Inc.
Akoya Biosciences Inc.
Kaleido Biosciences Inc.
Applied Genetic Technologies Corporation
Moderna
Assertio Holdings Inc.
Talis Biomedical Corporation
Sangamo Therapeutics Inc.
Lixte Biotechnology Holdings Inc.
Petros Pharmaceuticals Inc.
KALA PHARMACEUTICALS, INC
XBiotech Inc.
Orchard Therapeutics plc
Legend Biotech Corporation
Galapagos NV
Angion Biomedica Corp
Applied Dna Sciences Inc.
Esperion Therapeutics Inc.
Imara Inc.
Enanta Pharmaceuticals Inc.
Harpoon Therapeutics Inc.
Graphite Bio Inc.
Tiziana Life Sciences PLC
BioVie Inc
Applied Molecular Transport Inc.
Viveve Medical Inc.
Immuron Limited
Protara Therapeutics Inc.
4d molecular therapeutics
HOOKIPA Pharma Inc.
Pasithea Therapeutics Corp.
CASI PHARMACEUTICALS , INC
InMed Pharmaceuticals Inc.
Gain Therapeutics Inc.
NeuroBo Pharmaceuticals Inc.
Opiant Pharmaceuticals Inc
Lipocine Inc

Click the tags to see associated articles and topics

View Article Details
Mesoblast Limited (NASDAQ:MESO) Receives Consensus Rating of "Hold" from Brokerages ...

Added to Collection on: 2021-12-30 10:03:58

Tags for this article:

Finance
Money
Economy
Regenerative biomedicine
Mesoblast
Financial analyst
Securities research
Short
Investment management
Stock
Initial public offering
NASDAQ
Mesoblast Limited

Click the tags to see associated articles and topics

View Article Details
Patient Enrollment Commenced in Pivotal Phase 3 Trial of Rexlemestrocel-L for Chronic ...

Added to Collection on: 2024-07-22 00:58:20

Tags for this article:

Pain
Regenerative biomedicine
Human back
Mesoblast
Stem cells
Graft-versus-host disease
Pain management
Chronic pain
Regenerative Medicine Advanced Therapy
Back pain
Cell therapy
Low back pain
Mesoblast Limited

Click the tags to see associated articles and topics

View Article Details
Mesoblast (NASDAQ:MESO) versus Scinai Immunotherapeutics (NASDAQ:SCNI) Critical Review

Added to Collection on: 2024-09-22 12:11:42

Tags for this article:

Financial ratios
Regenerative biomedicine
Mesoblast
Graft-versus-host disease
Valuation
Price?earnings ratio
Earnings per share
Scinai Immunotherapeutics Ltd.
BiondVax Pharmaceuticals Ltd.
Mesoblast Limited
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details